DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial

Estrogen is thought to cause proliferation of all estrogen receptor positive (ER+) breast cancers. Paradoxically, in the Women's Health Initiative Trial, estrogen-only hormone replacement therapy reduced the incidence and mortality of low grade, ER+, HER2- breast cancer. We gave estradiol to 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Hugh, Judith C., Haddon, Lacey S.J., Githaka, John Maringa, Bigras, Gilbert, Hu, Xiuying, Madden, Brittney, Hanson, John, Gabos, Zsolt, Giannakopoulos, Nadia V., Huang, Fleur, Hitt, Mary M., McManus, Kirk J., Olson, David, Dabbs, Kelly, Mackey, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741439/
https://www.ncbi.nlm.nih.gov/pubmed/35028452
http://dx.doi.org/10.1016/j.heliyon.2021.e08666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741439/
https://www.ncbi.nlm.nih.gov/pubmed/35028452
http://dx.doi.org/10.1016/j.heliyon.2021.e08666

Ejemplares similares